Gene ‘cancer-proofs’ rodent’s cells

Gorbunova2

“We think we’ve found the reason these mole rats don’t get cancer, and it’s a bit of a surprise,” says Vera Gorbunova.

U. ROCHESTER (US)—Despite a 30-year lifespan that gives ample time for cells to grow cancerous, a small rodent species called a naked mole rat has never been found with tumors of any kind—and now biologists think they know why.

The findings, published in the Proceedings of the National Academy of Sciences, show that the mole rat’s cells express a gene called p16 that makes the cells “claustrophobic,” stopping the cells’ proliferation when too many of them crowd together, cutting off runaway growth before it can start.

The effect of p16 is so pronounced that when researchers mutated the cells to induce a tumor, the cells’ growth barely changed, whereas regular mouse cells became fully cancerous.

“We think we’ve found the reason these mole rats don’t get cancer, and it’s a bit of a surprise,” says Vera Gorbunova, associate professor of biology at the University of Rochester and lead investigator on the discovery. “It’s very early to speculate about the implications, but if the effect of p16 can be simulated in humans we might have a way to halt cancer before it starts.”

Naked mole rats are strange, ugly, nearly hairless mouse-like creatures that live in underground communities. Unlike any other mammal, these communities consist of queens and workers more reminiscent of bees than rodents. Naked mole rats can live up to 30 years, which is exceptionally long for a small rodent.

naked_mole_rats2

Naked mole rats can live up to 30 years, which is exceptionally long for a small rodent.

Despite large numbers of naked mole-rats under observation, there has never been a single recorded case of a mole rat contracting cancer, says Gorbunova. Adding to their mystery is the fact that mole rats appear to age very little until the very end of their lives.

Over the last three years, Gorbunova and Andrei Seluanov, research professor of biology, have worked an unusual angle on the quest to understand cancer: Investigating rodents from across the globe to get an idea of the similarities and differences of how varied but closely related species deal with cancer.

In 2006, Gorbunova discovered that telomerase—an enzyme that can lengthen the lives of cells, but can also increase the rate of cancer—is highly active in small rodents, but not in large ones.

Until Gorbunova and Seluanov’s research, the prevailing wisdom had assumed that an animal that lived as long as we humans do needed to suppress telomerase activity to guard against cancer. Telomerase helps cells reproduce, and cancer is essentially runaway cellular reproduction, so an animal living for 70 years has a lot of chances for its cells to mutate into cancer, says Gorbunova.

A mouse’s life expectancy is shortened by other factors in nature, such as predation, so it was thought the mouse could afford the slim cancer risk to benefit from telomerase’s ability to speed healing.

While the findings were a surprise, they revealed another question: What about small animals like the common grey squirrel that live for 24 years or more? With telomerase fully active over such a long period, why isn’t cancer rampant in these creatures?

Gorbunova sought to answer that question, and in 2008 confirmed that small-bodied rodents with long lifespans had evolved a previously unknown anti-cancer mechanism that appears to be different from any anticancer mechanisms employed by humans or other large mammals.

At the time she was not able to identify just what the mechanism might be, saying: “We haven’t come across this anticancer mechanism before because it doesn’t exist in the two species most often used for cancer research: mice and humans. Mice are short-lived and humans are large-bodied. But this mechanism appears to exist only in small, long-lived animals.”

Now, Gorbunova believes she has found the primary reason these small animals are staying cancer-free, and it appears to be a kind of overcrowding early-warning gene that the naked mole rat expresses in its cells.

When Gorbunova and her team began specifically investigating mole rat cells, they were surprised at how difficult it was to grow the cells in the lab for study. The cells simply refused to replicate once a certain number of them occupied a space. Other cells, such as human cells, also cease replication when their populations become too dense, but the mole rat cells were reaching their limit much earlier than other animals’ cells.

“Since cancer is basically runaway cell replication, we realized that whatever was doing this was probably the same thing that prevented cancer from ever getting started in the mole rats,” says Gorbunova.

Like many animals, including humans, the mole rats have a gene called p27 that prevents cellular overcrowding, but the mole rats use another, earlier defense in gene p16. Cancer cells tend to find ways around p27, but mole rats have a double barrier that a cell must overcome before it can grow uncontrollably.

“We believe the additional layer of protection conferred by this two-tiered contact inhibition contributes to the remarkable tumor resistance of the naked mole rat,” says Gorbunova in the PNAS paper.

Gorbunova and Seluanov are now planning to delve deeper into the mole rat’s genetics to see if their cancer resistance might be applicable to humans.

This research was funded by the National Institutes of Health and the Ellison Medical Foundation.

University of Rochester news: www.rochester.edu/news

chat6 Comments

You are free to share this article under the Creative Commons Attribution-NoDerivs 3.0 Unported license.

6 Comments

  1. Genes as Quiet as a Mouse: Why These Butt-Ugly Rodents Don’t Get Cancer | Sustainable Suppers

    […] more about the study here, in Futurity, a fantastic new science news aggregator that publishes studies from various universities. […]

  2. sally

    how simply amazing. I have become deaf to hearing cancer research results as while they are interesting, they all seem to tinker around the edges. But this seems like a whole new way to think about the situation. maybe?

  3. sam del mundo

    The obvious question: Have they tried to mutate the p16? and results??

  4. Vera Gorbunova

    We are working on it. The genome of naked mole rat is not sequenced, therefore before we can mutate or even just silence a gene we need to clone it. We hope that with publication of this paper the NIH will be more willing to invest in sequencing of the naked mole rat genome.

  5. sam del mundo

    Thanks for your reply. i’ve only been able to read your abstract (in PNAS), somehow, the whole article doesn’t come up.. so if you don’t mind one or two follow up questions.. IF ‘p16′ refers to a ca. 16 kD protein, can one obtain sufficient material to do say, an terminal AA sequence, and design anti-sense oligos from that?
    And while it was not entirely clear to me (from the abstract), if p16 is part of the p53 pathway. wouldn’t simple mutations of p53 show up in ‘cancer’ of the mole rat (regardless of the presence of ‘good’ p16)? And while i can appreciate the role of p16 in ‘solid’ tumours, has anybody tried to induce, say, a leukemia in the mole rat?
    i guess i am somewhat ‘bothered’ by the absence of any kind of ‘cancer’ in a multi-cellular organism (regardless of the ‘robustness’ of p16, etc.).
    But very fascinating work..and good luck with your future studies. cpacibo.
    sam

  6. Jenny Leonard

We respect your privacy.